269 related articles for article (PubMed ID: 9272766)
1. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
[TBL] [Abstract][Full Text] [Related]
2. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.
Poncelet M; Maruani J; Calassi R; Soubrié P
Neurosci Lett; 2003 Jun; 343(3):216-8. PubMed ID: 12770700
[TBL] [Abstract][Full Text] [Related]
3. Effects of SR141716A on ethanol and sucrose self-administration.
Freedland CS; Sharpe AL; Samson HH; Porrino LJ
Alcohol Clin Exp Res; 2001 Feb; 25(2):277-82. PubMed ID: 11236843
[TBL] [Abstract][Full Text] [Related]
4. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
[TBL] [Abstract][Full Text] [Related]
5. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.
Simiand J; Keane M; Keane PE; Soubrié P
Behav Pharmacol; 1998 Mar; 9(2):179-81. PubMed ID: 10065938
[TBL] [Abstract][Full Text] [Related]
6. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716.
Colombo G; Agabio R; Fà M; Guano L; Lobina C; Loche A; Reali R; Gessa GL
Alcohol Alcohol; 1998; 33(2):126-30. PubMed ID: 9566474
[TBL] [Abstract][Full Text] [Related]
7. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
8. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
Pério A; Barnouin MC; Poncelet M; Soubrié P
Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
[TBL] [Abstract][Full Text] [Related]
9. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study.
Freedland CS; Whitlow CT; Smith HR; Porrino LJ
Brain Res; 2003 Feb; 962(1-2):169-79. PubMed ID: 12543468
[TBL] [Abstract][Full Text] [Related]
10. The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat.
Gueudet C; Santucci V; Rinaldi-Carmona M; Soubrié P; Le Fur G
Neuroreport; 1995 Jul; 6(10):1421-5. PubMed ID: 7488739
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
Mansbach RS; Rovetti CC; Winston EN; Lowe JA
Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
[TBL] [Abstract][Full Text] [Related]
12. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Gallate JE; Saharov T; Mallet PE; McGregor IS
Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
[TBL] [Abstract][Full Text] [Related]
13. SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.
Costa B; Vailati S; Colleoni M
Behav Pharmacol; 1999 May; 10(3):327-31. PubMed ID: 10780247
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
15. The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats.
Dyr W; Ligieza J; Kostowski W
Alcohol; 2008 Sep; 42(6):509-12. PubMed ID: 18504086
[TBL] [Abstract][Full Text] [Related]
16. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
[TBL] [Abstract][Full Text] [Related]
17. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats.
Rowland NE; Mukherjee M; Robertson K
Psychopharmacology (Berl); 2001 Dec; 159(1):111-6. PubMed ID: 11797078
[TBL] [Abstract][Full Text] [Related]
18. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
Navarro M; Hernández E; Muñoz RM; del Arco I; Villanúa MA; Carrera MR; Rodríguez de Fonseca F
Neuroreport; 1997 Jan; 8(2):491-6. PubMed ID: 9080435
[TBL] [Abstract][Full Text] [Related]
19. SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.
Masserano JM; Karoum F; Wyatt RJ
Behav Pharmacol; 1999 Jul; 10(4):429-32. PubMed ID: 10780811
[TBL] [Abstract][Full Text] [Related]
20. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.
Terranova JP; Storme JJ; Lafon N; Péŕio A; Rinaldi-Carmona M; Le Fur G; Soubrié P
Psychopharmacology (Berl); 1996 Jul; 126(2):165-72. PubMed ID: 8856836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]